Showing 2,021 - 2,040 results of 60,588 for search '(( 5 ((ppm decrease) OR (mean decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.11s Refine Results
  1. 2021
  2. 2022
  3. 2023
  4. 2024
  5. 2025

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…Background<p>The increasing use of non-specific immunoglobulins (NSIGs) and their current shortage show a need for NSIGs’ use prioritization. …”
  6. 2026
  7. 2027
  8. 2028

    Argon Cluster Sputtering of a Hybrid Metal–Organic Surface: A Microscopic View by Oscar A. Restrepo (2001967)

    Published 2013
    “…According to the impact point, fragmentation of the polymer or the NP increases monotonically with the energy per atom in the projectile; i.e., the emission of fragments decreases monotonically with increasing cluster size at a given total energy. …”
  9. 2029
  10. 2030
  11. 2031
  12. 2032
  13. 2033
  14. 2034
  15. 2035

    Comparison of sensitivity and specificity of three diagnostic tests to detect <i>Schistosoma mansoni</i> infections in school children in Mwanza region, Tanzania by Antje Fuss (5675879)

    Published 2018
    “…The urine-based Point-of Care Circulating Cathodic Antigen (POC-CCA) test has been extensively evaluated as a further diagnostic tool. …”
  16. 2036

    Data extraction grid. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  17. 2037

    Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  18. 2038

    Inclusion criteria. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  19. 2039
  20. 2040

    PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”